EMERGENCY USE LISTING
Bharat Biotech Must Address WHO's COVID-19 Vaccine Covaxin Supply Suspension to Avoid Emergency Use Listing Cancellation in Future, Says MEA
No Impact of WHO Action on COVID-19 Vaccine Covaxin, Have Not Supplied to Any UN Agency, Says Bharat Biotech
Covaxin Latest Update: Bharat Biotech's Partner Ocugen Seeks Approval of COVID-19 Vaccine in America for Children Below 18 Years
COVAXIN Gets Emergency Use Listing Nod From WHO, Approval Expands Availability of COVID-19 Vaccines
COVID-19 Vaccine Latest Update: WHO Accepts Bharat Biotech's Expression of Interest for COVAXIN Emergency Use Listing, Awaiting Phase-3 Trials Data
Google Trends